| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/10/2022 | Bolt Biotherapeutics, Inc. | BOLT | Grant | Stock Option (Right to Buy) | 25k | $1.99 | $49.8k | | 06/10/2022 |
| 03/24/2022 | Bolt Biotherapeutics, Inc. | BOLT | Grant | Stock Option (Right to Buy) | 25k | $3.03 | $75.8k | | 03/24/2022 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 1.1M | $0.00 | $0 | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 317.9k | $0.00 | $0 | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 345.6k | $0.00 | $0 | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Sale | Common Stock | 144 | $20.00 | $2.9k | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Purchase | Common Stock | 175.7k | $20.00 | $3.5M | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 150.8k | $0.00 | $0 | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 43.9k | $0.00 | $0 | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 47.7k | $0.00 | $0 | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Sale | Common Stock | 20 | $20.00 | $400 | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series B Preferred Stock | 1.1M | $0.00 | $0 | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series C- 1 Preferred Stock | 317.9k | $0.00 | $0 | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series C- 2 Preferred Stock | 345.6k | $0.00 | $0 | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Exercise (in-the-money or at-the-money) | Warrant (Right to Buy) | 41k | $0.07 | $2.9k | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series B Preferred Stock | 150.8k | $0.00 | $0 | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series C- 1 Preferred Stock | 43.9k | $0.00 | $0 | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series C- 2 Preferred Stock | 47.7k | $0.00 | $0 | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Exercise (in-the-money or at-the-money) | Warrant (Right to Buy) | 5.7k | $0.07 | $395.8 | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Purchase | Common Stock | 24.3k | $20.00 | $485.3k | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/05/2018 | SOLENO THERAPEUTICS INC | SLNO | Grant | Common Stock | 5.1k | $1.73 | $8.7k | See footnotes | 02/05/2018 |
| 12/15/2017 | SOLENO THERAPEUTICS INC | SLNO | Purchase | Common Stock Warrant (Right to Buy) | 9.3k | $2.00 | $18.6k | See footnote | 12/15/2017 |
| 12/15/2017 | SOLENO THERAPEUTICS INC | SLNO | Purchase | Common Stock Warrant (Right to Buy) | 793.9k | $2.00 | $1.6M | See footnote | 12/15/2017 |
| 12/15/2017 | SOLENO THERAPEUTICS INC | SLNO | Purchase | Common Stock | 12.6k | $1.84 | $23.2k | See footnote | 12/15/2017 |
| 12/15/2017 | SOLENO THERAPEUTICS INC | SLNO | Purchase | Common Stock | 1.1M | $1.84 | $2M | See footnote | 12/15/2017 |
| 07/06/2017 | SOLENO THERAPEUTICS INC | SLNO | Grant | Common Stock | 14.3k | $0.61 | $8.7k | See footnote | 07/06/2017 |